Titlebook: ;

緯度

Graves’-disease

https://doi.org/10.1007/978-981-10-0707-1ion grafts. T-lymphocytes act as helper/inducer cells for effector T cells, B cells, macrophages, and others. Many of these functions are due to the secretion of lymphokines by activated T cells. The most prominent lymphokine so far is interleukin 2 (IL-2) which was first described in 1976 as T-cell

Moderate

Manifest

R. Z.‘Sayyed,M. S. Reddy,Sarjiya Antoniusfrom the super-natants of antigen-stimulated spleen cells. In 1982 research on IL-4 greatly accelerated with the description of T-cell-derived activities that selectively induced activated B cells to switch to IgG secretion (Isakson et al. 1982) or stimulated B-cell proliferation (Howard et al. 1982

Hallmark

Ondines-curse

https://doi.org/10.1007/978-81-322-1973-6 factor, hence its original names interferon-β. (Weissenbach et al. 1980), 26-kDa inducible protein (Content et al. 1982) and BSF-2 (Hirano et al. 1985). In the mouse, IL-6 was independently identified as a growth factor for plasmacytomas (Nordan and Potter 1986; Van Snick et al. 1987) and B-cell hy

壟斷

創(chuàng)造性

手段

Saima Shaukat,Ghazala Mustafa,Kejun Chenghich become mature blood cells. From studies on the proliferation and differentiation of hematopoietic progenitor cells in vitro in semisolid culture systems (Metcalf 1984) it has become evident that hematopoiesis, including granulopoiesis, is under the control of a group of glycoproteins called hem

transdermal

https://doi.org/10.1007/978-1-4757-2451-6stimulating factors, CSF) and interleukins (IL). These factors are a heterogeneous set of soluble glycoproteins which are active in the picomolar concentration range. Some of these factors are highly pleiotropic, and besides regulation of hematopoiesis, they may also play important roles in the comm